Issues relating to exports of pharmaceutical products will also be brought in by the Indian side. In China, Indian pharma companies face regulatory hurdles in the form of prolonged and unpredictable timelines for registering Indian drugs, which have adversely impacted expansion plans of these firms.
Read more: India aims to boost exports of fruits and vegetables to China